Results 141 to 150 of about 9,998 (163)

The lupus coagulation inhibitor and venous thrombosis: a report of four cases

International Journal of Laboratory Hematology, 1980
H, Williams, R, Laurent, T, Gibson
exaly   +3 more sources

The Mode of Action of a Coagulation Inhibitor in the Blood of Two Patients with Disseminated Lupus Erythematosus (DLE)

British Journal of Haematology, 1964
R Biggs, K W Denson
exaly   +3 more sources

Natural inhibitors of blood coagulation and fibrinolysis in patients with lupus anticoagulant

Blood Coagulation & Fibrinolysis, 1992
We studied the natural inhibitors (NI) of blood coagulation and fibrinolysis in 50 patients with lupus anticoagulant (LA), in order to identify possible alterations of these NI, that could favour thrombotic manifestations. We found no statistically significant difference in antithrombin III, protein C and alpha 2-antiplasmin between controls and ...
L C, Kordich, R R, Forastiero, E, Basilotta, P, Porterie, L O, Carreras   +4 more
openaire   +2 more sources

Circulating inhibitors of blood coagulation associated with procainamide‐induced lupus erythematosus

American Journal of Hematology, 1978
AbstractWe studied a patient being treated with procainamide in whom we observed a high antinuclear antibody titer and prolonged activated partial thromboplastin (PTT), prothrombin (PT), and Stypven times (ST). Serum antibody concentrations against single‐stranded DNA were elevated while those against native DNA were not elevated, suggesting the ...
S, Davis, B C, Furie, J H, Griffin, B, Furie, R, Willey   +4 more
openaire   +2 more sources

Changes in Components of the Natural Coagulation Inhibitor System, in Patients with Antiphospholipid Antibodies and/or the Lupus Inhibitor.

Blood, 2006
Abstract The cell surface glycoproteins thrombomodulin (TM) and endothelial protein C receptor (EPCR) are major intermediaries in the down-regulation of thrombin and are noted to be shed from endothelial cells (ECs) due to the actions of proinflammatory cytokines, thrombin and other agents.
Xuam Lam, Jeffrey Birnbaum, Evelyn Y. Ku, De-Hui W. Ku, Yale S. Arkel   +4 more
openaire   +1 more source

Acquired Inhibitors of Coagulation in a Patient With Systemic Lupus Erythematosus and Antiphospholipid Antibodies: Response to Rituximab

Reumatología Clínica (English Edition), 2008
Hematologic signs of systemic lupus erythematosus are diverse (SLE). Although a delayed coagulation time is anti-phospholipid antibody related, thrombotic events are the usual clinical manifestation. Spontaneous appearance of circulating anticoagulant in the absence of a previous coagulation disorder is secondary to the development of antibodies to ...
Enrique, Ortiz Jiménez, Sergio, Loera Fragoso, Marina, Rull Gabayet   +2 more
openaire   +2 more sources

[Circulating lupus coagulation inhibitor in two sisters, one with disseminated lupus erythematosus and the other with immunologic thrombocytopenic purpura].

La Revue de medecine interne, 1993
Familial cases of lupus anticoagulant were rarely described. We report the observation of two sisters with lupus anticoagulant, one with thrombocytopenic purpura and the other with systemic lupus erythematosus.
J, Constans, A, Le Hérissier, C, Vergnes, R, Roudaut, P, Durandet, P, Gosse, M, Dallocchio   +6 more
openaire   +1 more source

Report of the Working Party on Acquired Inhibitors of Coagulation: Studies of the “Lupus” Anticoagulant

Thrombosis and Haemostasis, 1983
D, Green, C, Hougie, F J, Kazmier, K, Lechner, P M, Mannucci, C R, Rizza, Y, Sultan   +6 more
openaire   +2 more sources

LUPUS‐TYPE COAGULATION INHIBITOR IN HAIRY CELL LEUKAEMIA AND REOSOLUTION WITH SPLENECTOMY

British Journal of Haematology, 1987
A. S. Duncombe, R. G. Dalton, G. F. Savidge   +2 more
openaire   +1 more source

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

New England Journal of Medicine, 2020
Dan Hart, Sean Platton, John Pasi
exaly